Molecular diagnosis of pancreatic cancer by telomerase
端粒酶对胰腺癌的分子诊断
基本信息
- 批准号:11671249
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To assess the clinical significance of telomerase on the diagnosis and the treatment of pancreatic cancer, telomerase activity was evaluated using telomeric repeat amplification protocol in surgically resected pancreatic tissues and in pancreatic juice.When the cutoff value was set at 1.00, the positivity rate of telomerase activity in pancreatic cancer tissues was 96.1%, whereas all tissues of adenoma, pancreatitis, normal pancreas and normal pancreatic ducts were negative. We also measured telomerase activity in pancreatic juiced obtained from the patients with pancreatic disorders through balloon catheter inserted into the pancreatic duct with an i.v. injection of secretin. The positive rate of telomerase activity was 83.3% in pancreatic juice from carcinoma patients, whereas only 4.3% was positive in that from adenoma patients. All of pancreatic juice from pancreatitis patients were negative in telomerase activity. The results indicate that measurement of telomerase activity in pancreatic juice may serve as a useful diagnostic tool for the pancreatic cancer.Since telomerase is specifically activated in pancreatic cancer, telomerase could be a target for the treatment of pancreatic cancer. Telomerase activity was inhibited by the transduction of wild type p53 using recombinant adenovirus, followed by significant apoptosis. 9-Hyroxyellipticine specifically inhibited telomerase activity of pancreatic cancer cells. Meanwhile, the exposure of VP-16 increased telomerase activity. The degree of telomerase activation inversely correlated with the induction of apoptosis. These results suggest that telomerase may have an anti-apoptotic role.
为探讨端粒酶在胰腺癌诊断和治疗中的临床意义,采用端粒重复序列扩增法检测了手术切除的胰腺组织和胰液中端粒酶活性,以1.00为界值时,胰腺癌组织中端粒酶活性阳性率为96.1%,而腺瘤、胰腺炎、正常胰腺和正常胰管均为阴性。我们还检测了胰腺疾病患者胰腺液中端粒酶活性,这些胰腺液是通过将球囊导管插入胰管并静脉注射促胰液素获得的。癌性胰液端粒酶活性阳性率为83.3%,而腺瘤性胰液端粒酶活性阳性率仅为4.3%。胰腺炎患者胰液端粒酶活性均为阴性。结果表明,检测胰液中端粒酶活性可作为胰腺癌的诊断工具,端粒酶在胰腺癌中具有特异性激活,可作为胰腺癌治疗的靶点。用重组腺病毒转导野生型p53可抑制端粒酶活性,随后出现明显的凋亡。9-羟基椭圆藤碱特异性抑制胰腺癌细胞端粒酶活性。同时,VP-16的暴露增加了端粒酶活性。端粒酶的激活程度与细胞凋亡的诱导程度呈负相关。这些结果表明,端粒酶可能具有抗凋亡的作用。
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
永井英司 他: "膵癌の遺伝子診断"内科. 86. 882-884 (2000)
Eiji Nagai 等人:《胰腺癌的基因诊断》《内科》 86. 882-884 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizumoto K: "Diverse effects of 9-hydroxyellipticine on the chemosensitivitiy of human pancreatic cancer cells harboring p53 mutations."Cancer Lett.. 149. 85-94 (2000)
Mizumoto K:“9-羟基玫瑰树碱对携带 p53 突变的人胰腺癌细胞的化疗敏感性的多种影响。”Cancer Lett.. 149. 85-94 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizumoto K: "Molecular approach for the diagnosis and the treatment of pancreatic cancer : telomerase and centrosome."Shokakika. 30. 93-97 (2000)
Mizumoto K:“诊断和治疗胰腺癌的分子方法:端粒酶和中心体。”Shokakika。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizumoto K et al: "Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations"Cancer Lett.. 149. 85-94 (2000)
Mizumoto K 等人:“9-羟基玫瑰树碱对携带 p53 突变的人胰腺癌细胞的化疗敏感性的多种影响”Cancer Lett.. 149. 85-94 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
水元一博 他: "膵液の分子生物学的検討による膵癌早期診断の可能性"消化器内視鏡. 11. 1141-1146 (1999)
Kazuhiro Mizumoto 等人:“通过胰液分子生物学检查早期诊断胰腺癌的可能性”胃肠内窥镜检查。11. 1141-1146 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIZUMOTO Kazuhiro其他文献
MIZUMOTO Kazuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIZUMOTO Kazuhiro', 18)}}的其他基金
Construction of drug discovery library using PDX-3D method and discovery of novel therapeutic agents for pancreatic cancer
利用PDX-3D方法构建药物发现库并发现胰腺癌新治疗药物
- 批准号:
20H03754 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Induction of tumor-suppressing pancreatic stellate cell subpopulation by pancreatic cancer microenvironment reprogramming
通过胰腺癌微环境重编程诱导肿瘤抑制性胰腺星状细胞亚群
- 批准号:
15H04933 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biological and clinical significance of niche during carcinogenesis in pancreatic cancer
胰腺癌发生过程中生态位的生物学和临床意义
- 批准号:
25670585 - 财政年份:2013
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Identification of the key stromal cell responsible for desmoplasia of pancreatic cancer, elucidation of the origin of it, and regulation of its function
鉴定负责胰腺癌结缔组织形成的关键基质细胞,阐明其起源及其功能调节
- 批准号:
24390319 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A novel approach for early diagnosis and personalized therapy to pancreatic cancer by metabolic profiling
通过代谢分析进行胰腺癌早期诊断和个性化治疗的新方法
- 批准号:
23659654 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Gene expressions in microdissected target cells as the diagnostic markers of pancreatic cancer and the prediction of treatment outcome using nano-technology
显微切割靶细胞中的基因表达作为胰腺癌的诊断标志物以及利用纳米技术预测治疗结果
- 批准号:
18390368 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of genetic diagnosis system for pancreatic cancer using modified telomeric repeat amplification protocols and electrochemical array chip
使用改良端粒重复扩增方案和电化学阵列芯片开发胰腺癌基因诊断系统
- 批准号:
15390399 - 财政年份:2003
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of Nitric oxide synthase andCytochrome P450 enzyme on the inhibitory effect of sevoflumae on vascular relaxation
一氧化氮合酶和细胞色素P450酶对七氟哌啶醇抑制血管舒张作用的影响
- 批准号:
14571463 - 财政年份:2002
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anti-cancer chemoagents-triggered centrosome aberrance and its relationship with mitotic cell death in pancreatic cancer cells.
抗癌化学药物引发的中心体异常及其与胰腺癌细胞有丝分裂细胞死亡的关系。
- 批准号:
13671244 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF VOLATILE ANESTHETICS ON ENDOTHELIAL NITRIC OXIDE SYNTHESIS AND VASODILATION MEDIATED THOROUGH THE CaィイD12+ィエD1 INFLUX PROMOTED BY THE DEPLETION OF CaィイD12+ィエD1 IN ENDOPLASMIC RETICULUM
挥发性麻醉剂对内质网 CaiD12+D1 耗竭促进的 CaiD12+D1 内流介导的内皮一氧化氮合成和血管舒张的影响
- 批准号:
10671440 - 财政年份:1998
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Developing profiles for early pancreatic cancer through bioinformatics analysis
通过生物信息学分析开发早期胰腺癌的概况
- 批准号:
10044369 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Grant for R&D
Establishment of ultra-early pancreatic cancer detection algorithm by preclinical pancreatic cancer matching cohort
通过临床前胰腺癌匹配队列建立超早期胰腺癌检测算法
- 批准号:
21K07559 - 财政年份:2021
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of the diagnosis of early pancreatic cancer by analysis of pancreatic juice-derived exosomal microRNA
通过分析胰液来源的外泌体 microRNA 建立早期胰腺癌的诊断
- 批准号:
19K16844 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of imaging method for early pancreatic cancer by high-resolution PET using radiolabeled antibody
使用放射性标记抗体开发早期胰腺癌高分辨率 PET 成像方法
- 批准号:
19H03609 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
International educational program using web conference to detect early pancreatic cancer in Asia
利用网络会议检测亚洲早期胰腺癌的国际教育计划
- 批准号:
18K09945 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection
4D 蛋白质组学和超分辨率显微镜在细胞外囊泡和颗粒传播生物标志物发现中的应用,用于早期胰腺癌检测
- 批准号:
10737386 - 财政年份:2017
- 资助金额:
$ 1.98万 - 项目类别:
A cell-based liquid biopsy approach for early pancreatic cancer detection
用于早期胰腺癌检测的基于细胞的液体活检方法
- 批准号:
9288144 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Achievement of highly accurate diagnosis of early pancreatic cancer in Japanese patients through a comprehensive/integrated approach
通过综合/综合方法实现日本患者早期胰腺癌的高精度诊断
- 批准号:
15H05791 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
A cell-based liquid biopsy approach for early pancreatic cancer detection
用于早期胰腺癌检测的基于细胞的液体活检方法
- 批准号:
8909573 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Enhanced Contrast Imaging for Screening of Early Pancreatic Cancer
增强对比成像筛查早期胰腺癌
- 批准号:
7537923 - 财政年份:2008
- 资助金额:
$ 1.98万 - 项目类别:














{{item.name}}会员




